{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T22:09:38Z","timestamp":1781129378411,"version":"3.54.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000098","name":"NIH Clinical Center","doi-asserted-by":"publisher","award":["Z99CL999999"],"award-info":[{"award-number":["Z99CL999999"]}],"id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR000445"],"award-info":[{"award-number":["UL1TR000445"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011656","name":"College of Business and Economics, Radford University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011656","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jcyt.2022.12.006","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T20:57:21Z","timestamp":1674853041000},"page":"442-450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Optimizing a fully automated and closed system process for red blood cell reduction of human bone marrow products"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0638-0473","authenticated-orcid":false,"given":"Victoria Ann","family":"Remley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Underwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjian","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3693-9533","authenticated-orcid":false,"given":"Yihua","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Prochazkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Moses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen M.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Stroncek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Highfill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.jcyt.2022.12.006_bib0001","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1182\/bloodadvances.2018021162","article-title":"Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment","volume":"2","author":"Georges","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jcyt.2022.12.006_bib0002","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.3389\/fimmu.2019.01246","article-title":"Bone Marrow Transplantation 1957\u20132019","volume":"10","author":"Simpson","year":"2019","journal-title":"Front Immunol"},{"issue":"24","key":"10.1016\/j.jcyt.2022.12.006_bib0003","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.1182\/blood-2010-12-322214","article-title":"Twenty-five years of peripheral blood stem cell transplantation","volume":"117","author":"Korbling","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jcyt.2022.12.006_bib0004","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3109\/14653241003709660","article-title":"High recovery of mesenchymal progenitor cells with non-density gradient separation of human bone marrow","volume":"12","author":"Dal Pozzo","year":"2010","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1016\/j.jcyt.2022.12.006_bib0005","first-page":"577","article-title":"Fully automated, clinical-grade bone marrow processing: a single-centre experience","volume":"15","author":"Mazzanti","year":"2017","journal-title":"Blood Transfus"},{"issue":"1","key":"10.1016\/j.jcyt.2022.12.006_bib0006","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bbmt.2019.07.025","article-title":"Allogeneic Bone Marrow Transplantation versus Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies in Children: A Systematic Review and Meta-Analysis","volume":"26","author":"Shimosato","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jcyt.2022.12.006_bib0007","first-page":"107","article-title":"A comparison of two protocols for optimal red blood cell depletion using Sepax-2 device for ABO-major incompatible transplantation in adults","volume":"67","author":"Fantin","year":"2019","journal-title":"Curr Res Transl Med"},{"issue":"3","key":"10.1016\/j.jcyt.2022.12.006_bib0008","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.transci.2016.05.010","article-title":"An update on ABO incompatible hematopoietic progenitor cell transplantation","volume":"54","author":"Staley","year":"2016","journal-title":"Transfus Apher Sci"},{"issue":"2","key":"10.1016\/j.jcyt.2022.12.006_bib0009","first-page":"89","article-title":"Transplantation of major ABO-incompatible bone marrow depleted of red cells by hydroxyethyl starch","volume":"48","author":"Warkentin","year":"1985","journal-title":"Vox Sang"},{"issue":"3","key":"10.1016\/j.jcyt.2022.12.006_bib0010","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.transci.2007.03.006","article-title":"Impact of harvest product volume in erythrocyte depletion of allogeneic or autologous bone marrow using COBE spectra","volume":"36","author":"Soydan","year":"2007","journal-title":"Transfus Apher Sci"},{"issue":"4","key":"10.1016\/j.jcyt.2022.12.006_bib0011","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1365-2141.1994.tb06744.x","article-title":"Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation","volume":"87","author":"Bensinger","year":"1994","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.jcyt.2022.12.006_bib0012","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/sj.bmt.1705420","article-title":"Factors affecting volume reduction and red blood cell depletion of bone marrow on the COBE Spectra cell separator before haematopoietic stem cell transplantation","volume":"38","author":"Guttridge","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jcyt.2022.12.006_bib0013","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1182\/blood.V86.7.2842.2842","article-title":"Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease","volume":"86","author":"Korbling","year":"1995","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jcyt.2022.12.006_bib0014","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/bmt.2011.135","article-title":"Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation","volume":"46","author":"Rowley","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jcyt.2022.12.006_bib0015","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/14653240701851324","article-title":"Separation of adult bone marrow mononuclear cells using the automated closed separation system Sepax","volume":"10","author":"Aktas","year":"2008","journal-title":"Cytotherapy"},{"issue":"5","key":"10.1016\/j.jcyt.2022.12.006_bib0016","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3109\/14653249.2010.487900","article-title":"Multicenter cell processing for cardiovascular regenerative medicine applications: the Cardiovascular Cell Therapy Research Network (CCTRN) experience","volume":"12","author":"Gee","year":"2010","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1016\/j.jcyt.2022.12.006_bib0017","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/trf.13001","article-title":"Red blood cell depletion from bone marrow and peripheral blood buffy coat: a comparison of two new and three established technologies","volume":"55","author":"Sorg","year":"2015","journal-title":"Transfusion"},{"issue":"8307","key":"10.1016\/j.jcyt.2022.12.006_bib0018","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0140-6736(82)90003-4","article-title":"ABO-incompatible bone-marrow transplantation: removal of red blood cells from donor marrow avoiding recipient antibody depletion","volume":"2","author":"Blacklock","year":"1982","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jcyt.2022.12.006_bib0019","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.transci.2017.11.019","article-title":"Automated red blood cell depletion in ABO incompatible grafts in the pediatric setting","volume":"56","author":"Del Fante","year":"2017","journal-title":"Transfus Apher Sci"},{"issue":"1","key":"10.1016\/j.jcyt.2022.12.006_bib0020","first-page":"93","article-title":"Preparation of red-blood-cell-depleted marrow for ABO-incompatible marrow transplantation by density-gradient separation using the IBM 2991 blood cell processor","volume":"15","author":"Jin","year":"1987","journal-title":"Exp Hematol"},{"issue":"5","key":"10.1016\/j.jcyt.2022.12.006_bib0021","first-page":"377","article-title":"Hemopoietic stem cell processing: comparison of progenitor cell recovery using the Cobe 2991 cell washer and the Haemonetics V50 apheresis system","volume":"9","author":"Preti","year":"1992","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jcyt.2022.12.006_bib0022","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12967-017-1277-6","article-title":"Erythrocyte depletion from bone marrow: performance evaluation after 50 clinical-scale depletions with Spectra Optia BMC","volume":"15","author":"Kim-Wanner","year":"2017","journal-title":"J Transl Med"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324922010787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324922010787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:48:14Z","timestamp":1761443294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324922010787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1465324922010787"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2022.12.006","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing a fully automated and closed system process for red blood cell reduction of human bone marrow products","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2022.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of International Society for Cell & Gene Therapy.","name":"copyright","label":"Copyright"}]}}